Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | $1.73B | 51,624,384 | 35.50% | 64.50% | Net Selling | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $43.88B | 132,623,144 | 82.36% | 17.64% | Net Selling | Net Selling | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $547.19M | 58,711,584 | 64.97% | 21.95% | Net Selling | Net Selling | ||
| ADMA | ADMA BIOLOGICS INC | $2.15B | 238,159,176 | 79.68% | 20.32% | Net Selling | Net Selling | ||
| CORT | CORCEPT THERAPEUTICS INC | $4.29B | 106,374,020 | 28.22% | 71.78% | Net Buying | Net Buying | ||
| ABEO | ABEONA THERAPEUTICS INC | $255.58M | 57,049,023 | 47.41% | 52.59% | Net Selling | Net Selling | ||
| HALO | HALOZYME THERAPEUTICS INC | $7.63B | 118,017,000 | 78.05% | 21.95% | Net Selling | Net Selling | ||
| KRYS | KRYSTAL BIOTECH INC | $7.55B | 29,232,189 | 80.01% | 19.99% | Net Selling | Net Selling | ||
| NAGE | NIAGEN BIOSCIENCE INC | $353.15M | 80,080,488 | 18.63% | 81.37% | Net Buying | |||
| RPRX | ROYALTY PHARMA PLC | $27.67B | 576,856,753 | 61.89% | 17.28% | Net Selling | Net Selling | ||
| VCEL | VERICEL CORP | $1.63B | 50,763,319 | 91.13% | 8.87% | Net Selling | Net Selling | ||
| APLS | APELLIS PHARMACEUTICALS INC | $5.14B | 127,829,909 | 76.66% | 23.34% | Net Selling | Net Selling | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.62B | 57,840,614 | 77.07% | 22.93% | Net Selling | Net Selling | ||
| MNKD | MANNKIND CORP | $754.85M | 308,100,433 | 36.56% | 63.44% | Net Selling | Net Buying | ||
| TECH | BIO-TECHNE CORP | $8.18B | 156,453,292 | 97.79% | 2.21% | Net Buying | Net Selling | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.86B | 192,323,359 | 97.84% | 1.79% | Net Selling | Net Selling | ||
| EXEL | EXELIXIS INC | $11.14B | 259,708,689 | 94.72% | 5.28% | Net Selling | Net Selling | ||
| VCYT | VERACYTE INC | $2.56B | 79,458,427 | 66.88% | 33.12% | Net Selling | Net Selling | ||
| XOMA | XOMA ROYALTY CORP | $373.48M | 11,905,652 | 19.43% | 80.57% | Net Selling | Net Buying | ||
| REGN | REGENERON PHARMACEUTICALS INC | $81.68B | 105,719,806 | 68.82% | 31.18% | Net Selling | Net Selling | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $3.02B | 122,123,884 | 84.18% | 15.82% | Net Selling | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $113.44B | 254,034,190 | 92.82% | 1.52% | Net Selling | Net Selling | ||
| LGND | LIGAND PHARMACEUTICALS INC | $3.98B | 19,941,141 | 18.32% | 81.68% | Net Selling | Net Selling | ||
| UTHR | UNITED THERAPEUTICS CORP | $25.99B | 43,827,686 | 86.81% | 13.19% | Net Selling | Net Selling | ||
| INCY | INCYTE CORP | $18.73B | 199,014,486 | 77.98% | 22.02% | Net Selling | Net Selling | ||
| CRMD | CORMEDIX INC | $536.75M | 79,050,395 | 53.08% | 9.65% | Net Selling | Net Selling | ||
| MDXG | MIMEDX GROUP INC | $586.84M | 148,566,586 | 46.84% | 53.16% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.